Glaxo Says Its Covid-19 Antibody Drug Is Likely Effective Against Omicron
Print/DownloadEarly laboratory studies suggest that a Covid-19 antibody treatment developed by GlaxoSmithKline PLC and Vir Biotechnology Inc. is effective against the Omicron variant, the companies said, setting i…
Read More
